Abstract
A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy.
Original language | English |
---|---|
Pages (from-to) | 11291-11294 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 50 |
Issue number | 77 |
DOIs | |
State | Published - 28 Aug 2001 |